Phase 4
N=20
Comparison of Functional Vision Provided by AMO Tecnis Z9000 and Alcon SA60AT Acrysof
Cataract
Bottom Line
View on ClinicalTrials.gov: NCT00459303 ↗Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Feb 2014
Primary outcome: Primary: Best Corrected logMAR Contrast Acuity at Photopic/Mesopic Condition — 0.34; 0.34 log MAR
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- aspherical intraocular lens (Device); spherical intraocular lens (Device)
- Age
- Adult, Older Adult · 45+ yrs
- Sex
- All
- Sponsor
- National Taiwan University Hospital
- Primary completion
- Sep 2007
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Best Corrected logMAR Contrast Acuity at Photopic/Mesopic Condition |
0.34; 0.34 | — |
| PRIMARY Best Corrected Contrast Sensitivity in Photopic Condition |
47.03; 55.90; 82.64; 85.09; 69.31; 72.41 | — |
| SECONDARY Corneal High-order Aberrations |
0.10; 0.11 | — |
| SECONDARY Total Ocular High-order Aberrations |
0.6314; 0.0856 | — |
Summary
This study is to compare intraindividually the functional vision provided by two different posterior chamber intraocular lenses: AMO Tecnis Z9000 and Alcon SA60AT Acrysoft. To see if the aspherical intraocular lenses provide better functional vision than traditional spherical intraocular lenses.
Eligibility Criteria
Inclusion Criteria
- Bilateral cataracts, eligible for phacoemulsification with primary implantation of a posterior chamber IOL
- Willing and able to comply with scheduled visits and other study procedures
Exclusion Criteria
- Preoperative ocular pathology potentially affect visual acuity. EX: diabetic retinopathy, macular degeneration, corneal opacity, glaucoma, visual field defect...etc.
- Previous ocular surgery. Ex: refractive surgery, vitreoretinal surgery...etc.
- Patients who cannot cooperative with the study procedures
Data sourced from ClinicalTrials.gov (NCT00459303). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.